Building Health System Resiliency
We are working with partners globally to bring this much needed, antimicrobial innovation forward to better protect our healthcare workers and the public. We are actively expanding into the indoor air quality market and pursuing further PPE applications, including nitrile gloves, gowns, footwear, coverings, and surgical caps to bring enhanced protection to the global healthcare industry. ZenGUARD™ technology brings pathogen protection to hospitals, homes, and healthcare facilities to mitigate risks during this pandemic, as well as those undiscovered and future pandemic diseases.
Enhanced Bacterial and Viral Filtration Efficiency (BFE/VFE) greater than 99.99%*
— We believe a first for surgical masks.
ZenGUARD™-coated masks removed 98.9% more bacteria and 97.8% more virus compared to a typical ASTM Level 3, 3-ply uncoated, resulting in over 99.99% BFE and VFE ratings.
Proven Filtration
ZenGUARD™ is a hydrophilic, water attracting coating that adsorbs and filters bacteria and virus-laden aerosols, increasing public safety, and reducing the risk of transmission of pathogens.
The same ZenGUARD™ technology that enhances the effectiveness of PPE can be added to air filtration media used in HVAC systems to filter pathogens and improve air quality.
*Testing completed by GAPLAB Environmental Microbiology using a modified ASTM F2101:
| S. aureus | CFU BFE Challenge Level | Total CFU Recovered Averaged from 3 tests |
|---|---|---|
| Uncoated 3-ply | 6,966,700 | 38,500 |
| ZenGUARD™-coated 4-ply | 6,966,700 | 410 |
| MS2 Bacteriophage | PFU VFE Challenge Level | Total PFU Recovered Averaged from 3 tests |
|---|---|---|
| Uncoated 3-ply | 22,933,000 | 76,667 |
| ZenGUARD™-coated 4-ply | 22,933,000 | 1,683 |
Fostering Safer Communities
Zentek is actively exploring opportunities to take its cutting-edge nanotechnology outside the clinical setting to add advanced protection to air filtration systems - making travel, work, and our communities safer.
“We are bringing what we believe is a significant differentiator in the PPE space to those in Canada’s highest risk environments. Looking beyond our borders, the first regulatory approval of our technology for use on surgical masks is also significant as we continue developing our international growth strategy.—Greg Fenton, CEO
Prevention News
View all newsJuly 18, 2022
Zentek Files a Provisional Patent on the use of ZenGUARD™ as an Anti-Inflammatory Agent
Read now
May 26, 2022
Zentek Announces Opening of its Industrial Scale ZenGUARD™ Production Facility in Guelph, Ontario
Read now
May 13, 2022
Zentek Announces Sales and Distribution of ZenGUARD™ Masks through Mark’s in Canada
Read now
Get In Touch
Commercial Partners
Are you interested in our technology to enhance your product offering - or have an innovation that fits well with our focus areas and would like to work together?
Contact
Nick Hansford
nhansford@zentek.comSales & Partnerships
Are you interested in purchasing our products or discussing sales?
Contact
Ryan Shacklock
rshacklock@zentek.comResearch Community
Are you a researcher focused on new and innovative nanotechnologies and looking for a highly engaged development partner?
Contact
Adam MacIntosh
amacintosh@zentek.comGovernment
Are you a member of federal, provincial or international governments looking to invest, fund, collaborate, partner with, support, or help advance next-gen healthcare?
Contact
Monique Manaigre
mmanaigre@zentek.comExecutive & Administrative Inquiries
Are you looking for other company information?
Contact
Sandra Lombardo
slombardo@zentek.comInvestor Relations
Are you looking to discuss investor relations?
Contact
investorrelations@zentek.com